Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 2 , Pages 99-107 , February 2009

Pharmacotherapy of Pediatric Insomnia

  • Christopher J. Kratochvil, M.D. (Assistant Editor)
    • ,
  • Judith A. Owens, M.D., M.P.H.

      Affiliations

    • Corresponding Author InformationCorrespondence to Judith Owens, M.D., M.P.H., Division of Pediatric Ambulatory Medicine, Rhode Island Hospital, 593 Eddy Street, Potter Bldg., Suite 200, Providence, RI 02903

,Accepted 6 October 2008.

References 

  1. Mindell J , Kuhn B , Lewin D , Meltzer L , Sadeh A , Owens J . Behavioral treatment of bedtime problems and night wakings in infants and young children. An American Academy of Sleep Medicine Review . Sleep . 2006;29:1263–1276
  2. Mindell J , Owens J . A Clinical Guide to Pediatric Sleep: Diagnosis and Management of Sleep Problems in Children and Adolescents . Philadelphia: Lippincott Williams & Wilkins; 2003;
  3. Owens J , Rosen C , Mindell J . Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians . Pediatrics . 2003;111:e628–e635
  4. Owens JA , Babcock D , Blumer J , et al.   The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: Rational approaches. A consensus meeting summary . J Clin Sleep Med . 2005;1:49–59
  5. Feren S , Katyal A , Walsh J . Efficacy of hypnotic medications and other medications used for insomnia . Sleep Med Clin . 2006;1:387–397
  6. Pelayo R , Dubik M . Pediatric sleep pharmacology . Semin Pediatr Neurol . 2008;15:79–90
  7. Jan J , Wasdell M , Reiter R , et al.   Melatonin therapy of pediatric sleep disorders: recent advances, why it works, who are the candidates, and how to treat . Curr Pediatr Rev . 2007;3:214–224
  8. Meoli A , Rosen C , Kristo D , et al.   Oral non-prescription treatment for insomnia: an evaluation of products with limited evidence . J Clin Sleep Med . 2005;1:173–187
  9. Weiss M , Wasdell MB , Bomben MM , et al.   Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia . J Am Acad Child Adolesc Psychiatry . 2007;46:233–241

 Psychopharmacology Perspectives aims to discuss practical approaches to everyday issues in pediatric pharmacotherapy. The discussions may address aspects of clinical care related to psychopharmacology for which we do not have adequate applicable controlled trials. Given the need to address symptoms in youths with often complex, severe, and comorbid disorders, recommendations are likely to be off-label from the perspective of the U.S. Food and Drug Administration. We fully appreciate that for virtually all disorders, medication is only one aspect of comprehensive care. This column focuses primarily on psychopharmacological management. Although it is important that clinicians address psychosocial issues in the evaluation and treatment of their patients, such discussion is beyond the specific scope of this feature. These are not meant to be practice guidelines but rather examples of the thought process that may go into pharmacotherapy decision making.

PII: S0890-8567(09)60003-4

doi: 10.1097/CHI.0b013e3181930639

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 2 , Pages 99-107 , February 2009

Article Tools